FDA Alerts
Blood-Thinning Rx Had No Effect on Mortality
(US Food and Drug Administration): A U.S. Food and Drug Administration (FDA) review has determined that long-term use of the blood-thinning drug Plavix (clopidogrel) does not increase or decrease overall risk of death in patients with, or at risk for, heart disease.
FDA Warns About Sexual Enhancement Product
The Food and Drug Administration (FDA) is advising consumers not to purchase or use Power Khan, a product promoted for sexual enhancement.
First Rx for Rare Disease Gets FDA OK
Today, the U.S. Food and Drug Administration approved Strensiq (asfotase alfa) as the first approved treatment for perinatal, infantile and juvenile-onset hypophosphatasia (HPP).
Sterile Drug Products Recalled
The U.S. Food and Drug Administration is alerting health care professionals and patients of a voluntary recall of all non-expired drug products produced for sterile use and distributed nationwide by Medistat RX, LLC, in Foley, Alabama, due to possible contamination.
Orphan Rx for Rare Metabolic Disorder Approved
Today, the U.S. Food and Drug Administration approved Xuriden (uridine triacetate), the first FDA-approved treatment for patients with hereditary orotic aciduria.
Rare Brain Infections Tied to MS Rx
FDA is warning that a case of definite progressive multifocal leukoencephalopathy (PML) and a case of probable PML have been reported in patients taking Gilenya (fingolimod) for multiple sclerosis (MS).
Soft Tissue Fillers in Face May Pose Risks
The US Food and Drug Administration (FDA) today issued a warning regarding the unintentional injection of soft tissue filler into blood vessels in the face.
FDA: Diabetes Rx May Pose Serious Health Risk
The U.S. Food and Drug Administration (FDA) is warning that the type 2 diabetes medicines canagliflozin, dapagliflozin, and empagliflozin may lead to ketoacidosis, a serious condition where the body produces high levels of blood acids called ketones that may require hospitalization.
FDA Approves Test for Delayed Gastric Emptying
The U.S. Food and Drug Administration today approved the Gastric Emptying Breath Test (GEBT), a new non-invasive test to aid in the diagnosis of delayed gastric emptying, known as gastroparesis.
Trader Joe's Recalls Raw Walnuts
Trader Joe’s Company is recalling Raw Walnuts because these products have the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems.